twiist Review - Here's What We Think After 2 Months Using the Pump
I used the twiist tubed pump from Sequel Med Tech for over 2 months and break down how it works day to day, iPhone and app watch control, settings and alerts and my glucose control results.
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
How Secure Is Your Insulin Pump? A Cybersecurity Expert Explains
A cybersecurity expert explains the precautions behind insulin pumps, CGMs, and why managing diabetes in secure government facilities requires a different level of protection.
We unpack how major companies are reimagining insulin delivery through tubeless designs, smarter algorithms, and the path to a fully automated insulin system.
We Spoke with Breakthrough T1D’s CEO About its Mission to Cure Type 1 Diabetes
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
Novo Nordisk Shuts Down Cell Therapy Unit—What the Community Is Saying
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
FDA Moves Forward With Review Of Inhaled Insulin For Children
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
T1Ds Are Using GLP-1s: The Latest Research & The Road To Coverage
Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.
Diagnosed With Type 1.5 Diabetes — A LADA Diagnosis Story
Many adults diagnosed later in life may actually have LADA or type 1.5 diabetes — here’s how it works, how it differs, and a story navigating diagnosis.
